KORU Medical SystemsKRMD -3.49%76 Days Payable is 49.34 as of Mar. 2026, which is 34% above its 10-year median of 36.85. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued). Among 794 Medical Devices & Instruments companies, KORU Medical Systems ranks worse than 72.17% on this metric.
The historical rank and industry rank for KORU Medical Systems's Days Payable or its related term are showing as below:
KRMD'
s Days Payable Range Over the Past 10 Years
Min: 21.65 Med: 36.85 Max: 52.74
Current: 43.81
During the past 13 years, KORU Medical Systems's highest Days Payable was 52.74. The lowest was 21.65. And the median was 36.85.
KRMD's Days Payable is ranked worse than 72.17% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs KRMD: 43.81
KORU Medical Systems's Days Payable
increased
from Mar. 2025 (46.58) to Mar. 2026 (49.34).
It may suggest that KORU Medical Systemsdelayed paying its suppliers.
KORU Medical Systems Days Payable Related Terms
KORU Medical Systems Days Payable Historical Data
* Premium members only.
The historical data trend for KORU Medical Systems's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KORU Medical Systems Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Days Payable distribution charts can be found below:
* The bar in red indicates where KORU Medical Systems's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
KORU Medical Systems's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KORU Medical Systems (KRMD) has a Days Payable of 49.34 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on KORU Medical Systems and its competitors. This is 34% above median its historical median of 36.85. Over the past decade, KORU Medical Systems' Days Payable has ranged from 21.65 to 52.74. According to the industry distribution chart, KORU Medical Systems ranks #573 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is KORU Medical Systems' Days Payable too high?
KORU Medical Systems' current Days Payable of 49.34 is 34% above median its 10-year median of 36.85. Over the past 10 years, this metric has ranged from a low of 21.65 to a high of 52.74. The Medical Devices & Instruments industry median Days Payable is 67.97. KORU Medical Systems' value of 49.34 is 27.4% below this industry median. Based on the distribution chart, KORU Medical Systems ranks #573 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Days Payable compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #573 out of 794 companies for Days Payable. This places KORU Medical Systems in the lower half of its industry. The industry median Days Payable is 67.97. KORU Medical Systems' value of 49.34 is 27.4% below this benchmark. Historically, KORU Medical Systems' own Days Payable has ranged from 21.65 to 52.74 over the past decade. While the company's 10-year median is 36.85 vs. the industry median of 67.97, KORU Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KORU Medical Systems's current Days Payable of 49.34 is 27.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on KORU Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current Days Payable is 49.34, which is 34% above median its own 10-year median of 36.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.43 — trading 8.6% above its estimated fair value. The current Days Payable is 49.34, which is 34% above median its 10-year median of 36.85 and 27.4% below the Medical Devices & Instruments industry median of 67.97. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Days Payable is 49.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KORU Medical Systems (KRMD) Overvalued in 2026?
Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued.
The current stock price of $4.43 is trading 8.6% above its estimated GF Value™ of $4.08.
GuruFocus considers KORU Medical Systems to be Fairly Valued.
Key valuation signals for KRMD:
Days Payable: 49.34 (34% above median its 10-year median of 36.85)
GF Value™: $4.08 vs. price of $4.43 (8.6% above fair value)
Industry Position: 27.4% below the Medical Devices & Instruments median (#573 of 794)
No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score
Get the complete analysis for KRMD
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRMD has been successfully added to your 
